MarketPeel
Insider Trading Intelligence
Pricing
…
RW

Rick E. Winningham

TBPH
CHIEF EXECUTIVE OFFICER · THERAVANCE BIOPHARMA, INC. · CIK 0001302443
FILING MIX · LIFETIME36%/64%
BUYS
24
SELLS
42
TOTAL VALUE
$15.53M
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
1,640,623
AVG SELL PX
$18.61
TRADE KIND
SHOWING 66 / 66
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Rick E. Winningham, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%+0.77%+0.98%-0.21%-0.99%—
14d4+75.00%-1.94%-0.12%-1.82%-0.64%—
30d4+50.00%-1.04%+0.35%-1.39%+1.32%—
60d4+75.00%-3.44%-0.67%-2.78%-5.51%—
90d4+75.00%+0.75%-0.14%+0.88%-0.97%—
180d4+25.00%+10.74%+9.44%+1.29%+2.57%—
1y4(1 pending)+66.67%+1.01%+21.57%-20.56%-21.82%—
2y4(1 pending)+66.67%-5.60%+37.41%-43.01%-56.59%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TBPH · 1,631,056 shares · as of May 20, 2026
0463,160926,3211,389,4811,852,641202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 24 buys / 42 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
2,741$241.57$662.1K9,567May 22, 2026May 27, 2026 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASE
3,415$138.08$471.5K12,308May 22, 2026May 27, 2026 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
3,415——0May 22, 2026May 27, 2026 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
20,038$16.55$331.6K1,631,056May 20, 2026May 22, 2026 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
75,000——1,651,094Apr 1, 2026Apr 3, 2026 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
74,975$19.66$1.47M1,576,094Feb 20, 2026Feb 24, 2026 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
56,817$17.90$1.02M1,651,069Nov 20, 2025Nov 21, 2025 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Gift
9,900——23,400Nov 19, 2025Nov 21, 2025 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALEGRANT
Gift
9,900——1,707,886Nov 19, 2025Nov 21, 2025 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
5,500$180.86$994.7K8,893Nov 18, 2025Nov 20, 2025 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
15,394$13.39$206.1K1,717,786Aug 20, 2025Aug 22, 2025 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,805$111.25$200.8K14,393Aug 8, 2025Aug 11, 2025 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
3,507——16,198Aug 7, 2025Aug 11, 2025 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALEGRANT
Gift
20,000——1,733,180Jun 23, 2025Jun 25, 2025 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Gift
9,600——13,500Jun 13, 2025Jun 17, 2025 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALEGRANT
Gift
9,600——1,753,180Jun 13, 2025Jun 17, 2025 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
15,364$9.45$145.2K1,762,780May 20, 2025May 22, 2025 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
2,178$9.35$20.4K1,778,144Feb 28, 2025Mar 4, 2025 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
35,129$9.66$339.3K1,775,966Feb 20, 2025Feb 24, 2025 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
15,997$9.97$159.5K1,811,095Nov 20, 2024Nov 22, 2024 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
3,193$9.57$30.6K1,827,092Nov 14, 2024Nov 19, 2024 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
15,997$8.22$131.5K1,823,899Aug 20, 2024Aug 22, 2024 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
3,252$7.83$25.5K1,839,896Aug 7, 2024Aug 9, 2024 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,484$111.35$165.2K12,691Aug 6, 2024Aug 6, 2024 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
3,731——14,175Aug 2, 2024Aug 6, 2024 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
15,997$9.10$145.6K1,836,644May 20, 2024May 22, 2024 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
2,068$9.85$20.4K1,852,641May 15, 2024May 17, 2024 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
300,000——1,850,573Apr 2, 2024Apr 4, 2024 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALEGRANT
Gift
3,900——1,550,573Mar 15, 2024Mar 19, 2024 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALEGRANT
Gift
7,000——1,554,473Mar 15, 2024Mar 19, 2024 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Gift
3,900——3,900Mar 15, 2024Mar 19, 2024 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
2,704$8.64$23.4K1,561,473Mar 15, 2024Mar 19, 2024 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
37,196$8.92$331.8K1,558,769Feb 20, 2024Feb 22, 2024 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
15,804$10.37$163.9K1,595,965Nov 20, 2023Nov 22, 2023 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
15,804$9.70$153.3K1,611,769Aug 20, 2023Aug 22, 2023 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,241$138.16$171.5K10,444Aug 14, 2023Aug 15, 2023 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
3,075——11,685Aug 11, 2023Aug 15, 2023 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
15,804$11.21$177.2K1,627,573May 20, 2023May 23, 2023 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
330,000——1,643,377Mar 1, 2023Mar 3, 2023 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
37,420$10.44$390.7K1,313,377Feb 20, 2023Feb 22, 2023 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
50,000$11.19$559.5K1,350,797Dec 14, 2022Dec 16, 2022 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALEGRANT
Gift
9,000——1,400,797Dec 13, 2022Dec 16, 2022 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
15,804$10.85$171.5K1,409,797Nov 20, 2022Nov 22, 2022 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
15,804$9.34$147.6K1,424,784Aug 19, 2022Aug 23, 2022 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,089$152.32$165.9K8,610Aug 8, 2022Aug 9, 2022 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
2,561——9,699Aug 5, 2022Aug 9, 2022 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
11,025$8.74$96.4K1,440,588May 20, 2022May 24, 2022 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
170,000——1,449,300Feb 25, 2022Mar 1, 2022 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
515,000——515,000Feb 25, 2022Mar 1, 2022 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
22,710$9.61$218.2K1,279,300Feb 18, 2022Feb 23, 2022 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
CHIEF EXECUTIVE OFFICER
11,404$8.36$95.3K1,302,010Nov 19, 2021Nov 23, 2021 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
Chief Executive Officer
11,404$14.05$160.2K1,313,414Aug 20, 2021Aug 24, 2021 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,306$147.96$193.2K7,138Aug 6, 2021Aug 10, 2021 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
2,246——8,444Jul 29, 2021Aug 2, 2021 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
Chief Executive Officer
11,404$17.80$203.0K1,324,818May 20, 2021May 24, 2021 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
Chief Executive Officer
110,348$18.79$2.07M1,334,821Feb 20, 2021Feb 23, 2021 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
170,000——1,445,169Feb 8, 2021Feb 10, 2021 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
Chief Executive Officer
13,946$17.21$240.0K1,275,169Nov 20, 2020Nov 24, 2020 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
Chief Executive Officer
13,946$18.22$254.1K1,289,115Aug 20, 2020Aug 24, 2020 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
931$125.87$117.2K6,198Aug 7, 2020Aug 10, 2020 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
2,705——7,129Aug 6, 2020Aug 10, 2020 ↗View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
6,765——6,765Aug 6, 2020Aug 10, 2020 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
Chief Executive Officer
13,946$26.67$371.9K1,303,061May 20, 2020May 22, 2020 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
SALE
Chief Executive Officer
96,850$25.90$2.51M1,315,605Feb 20, 2020Feb 24, 2020 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
168,000——1,412,455Feb 3, 2020Feb 5, 2020 ↗View →
TBPH
THERAVANCE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
170,000——1,244,455Feb 3, 2020Feb 5, 2020 ↗View →
Other insiders · TBPH
Loading peer insiders…
About this filer
CIK 0001302443
ROLE
CHIEF EXECUTIVE OFFICER
PRIMARY
TBPH
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001302443DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback